Gene Therapy Delivering the Longevity-Associated Variant of BPIFB4 Improves Immune Function in Old Mice

In conclusion, the new senotherapeutic action of LAV-BPIFB4 may offer a valuable therapeutic tool to control aging and reduce the burden of its pathophysiological disorders, such as CVDs. Link: https://doi.org/10.1038/s41419-022-04535-z
Source: Fight Aging! - Category: Research Authors: Tags: Daily News Source Type: blogs